dAquino AI, Maikawa CL, Nguyen LT, et al
It is important to note that while this has been shown to have incredible weight loss results, it should be used within a treatment care plan that potentially also involves diet and exercise regimens, and it closely monitored by a health care professional that is aware of the medical history and lifestyle habits of the patient
Serum samples were analyzed for liver function markers (Alanine transferase/ALT, Aspartate transferase/AST), renal function markers (Urea nitrogen, Creatinine/Cr), and myocardial enzyme indexes (Creatine Kinase/CK, Creatine Kinase-MB/CK-MB, Lactate Dehydrogenase-L/LDH-L)
The findings indicate that GLP-1 agonists may be an effective therapy to avoid severe liver disease in those with concurrent type 2 diabetes, according to the study authors
April 15, 2024